These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8405702)

  • 1. Functional activity of plasma fibronectin in patients with diabetes mellitus.
    Di Girolamo N; Underwood A; McCluskey PJ; Wakefield D
    Diabetes; 1993 Nov; 42(11):1606-13. PubMed ID: 8405702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin.
    Schor SL; Ellis I; Dolman C; Banyard J; Humphries MJ; Mosher DF; Grey AM; Mould AP; Sottile J; Schor AM
    J Cell Sci; 1996 Oct; 109 ( Pt 10)():2581-90. PubMed ID: 8923219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enzyme-linked immunoassay for direct measurement of the gelatin-binding capacity of human plasma fibronectin.
    Damas P; Adam A; Closset J; Calay G; Foidart JM; Lamy M; Foidart J; Mahieu P
    J Immunol Methods; 1986 Jul; 91(2):205-11. PubMed ID: 3734459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly.
    Nagai T; Yamakawa N; Aota S; Yamada SS; Akiyama SK; Olden K; Yamada KM
    J Cell Biol; 1991 Sep; 114(6):1295-305. PubMed ID: 1716636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the opsonic and monocyte adherence functions of the specific fibronectin fragment that enhances phagocytosis of particulate activators.
    Czop JK; Kadish JL; Zepf DM; Austen KF
    J Immunol; 1985 Mar; 134(3):1844-50. PubMed ID: 3968434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A weaker gelatin-binding affinity and increased glycosylation of amniotic fluid fibronectin than plasma fibronectin.
    Yamaguchi Y; Isemura M; Yosizawa Z; Kan M; Sato A
    Int J Biochem; 1986; 18(5):437-43. PubMed ID: 3709931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased adhesion to fibronectin and Mo-1 expression by diabetic monocytes.
    Setiadi H; Wautier JL; Courillon-Mallet A; Passa P; Caen J
    J Immunol; 1987 May; 138(10):3230-4. PubMed ID: 2952713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
    Davis TM; Moore JC; Turner RC
    Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and tissue fibronectin in diabetes.
    Labat-Robert J; Leutenegger M; Llopis G; Ricard Y; Derouette JC
    Clin Physiol Biochem; 1984; 2(1):39-48. PubMed ID: 6386277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of Human Plasma/Cellular Fibronectin and Fibronectin Fragments.
    Pietrocola G; Rindi S; Nobile G; Speziale P
    Methods Mol Biol; 2017; 1627():309-324. PubMed ID: 28836210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-diagnostic significance of fibronectin determination in diabetes mellitus in children].
    Popova VA; Ostashevskaia MI; Podgorodnichenko VK
    Pediatriia; 1990; (6):9-12. PubMed ID: 2395632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location of a fibronectin domain involved in newt epidermal cell migration.
    Donaldson DJ; Mahan JT; Hasty DL; McCarthy JB; Furcht LT
    J Cell Biol; 1985 Jul; 101(1):73-8. PubMed ID: 4008536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin quantification without antibodies: a bioassay for the detection of the gelatin-captured macromolecule.
    Pataki A; Madarász E; Kurucz I
    J Biochem Biophys Methods; 2006 Aug; 68(2):113-26. PubMed ID: 16780955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of plasma fibronectin concentration in type 1 diabetic patients].
    Zozulińska D; Derc K; Majchrzak A; Szczepanik A; Wierusz-Wysocka B
    Pol Arch Med Wewn; 1999 Sep; 102(3):773-7. PubMed ID: 10949884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitus.
    Skrha J; Vacková I; Kvasnicka J; Stibor V; Stolba P; Richter H; Hörmann H
    Eur J Clin Invest; 1990 Apr; 20(2):171-6. PubMed ID: 2112482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A competitive inhibition assay for gelatin binding fibronectin.
    Doran JE; Callaway BD; Reese AC; Wynn JJ; Mansberger AR
    Vox Sang; 1983; 45(3):243-51. PubMed ID: 6624010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus.
    Tarsio JF; Wigness B; Rhode TD; Rupp WM; Buchwald H; Furcht LT
    Diabetes; 1985 May; 34(5):477-84. PubMed ID: 3987974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human plasma fibronectin. Comparison of methods for preparation of a concentrate for therapeutic use from different sources].
    Regnault V; Rivat C; Geschier C; Stoltz JF
    Rev Fr Transfus Hemobiol; 1990 Dec; 33(6):391-405. PubMed ID: 2285448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation. Implications for diabetes mellitus.
    Tarsio JF; Reger LA; Furcht LT
    Biochemistry; 1987 Feb; 26(4):1014-20. PubMed ID: 3567152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of culture-derived macrophages with the fibroblast-binding domain of fibronectin is a necessary but inefficient signal for fibronectin enhancement of CR1-mediated phagocytosis.
    Bohnsack JF; Takahashi T; Brown EJ
    J Immunol; 1986 May; 136(10):3793-8. PubMed ID: 2939134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.